Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Development of a Multiplexed Assay for Detection of Leishmania donovani and Leishmania infantum Protein Biomarkers in Urine Samples of Patients with Visceral Leishmaniasis.

Abeijon C, Alves F, Monnerat S, Wasunna M, Mbui J, Viana AG, Bueno LL, Siqueira WF, Carvalho SG, Agrawal N, Fujiwara R, Sundar S, Campos-Neto A.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e02076-18. doi: 10.1128/JCM.02076-18. Print 2019 May.

PMID:
30787142
2.

Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis.

Abeijon C, Dilo J, Tremblay JM, Viana AG, Bueno LL, Carvalho SFG, Fujiwara RT, Shoemaker CB, Campos-Neto A.

Parasite Immunol. 2018 Nov;40(11):e12584. doi: 10.1111/pim.12584. Epub 2018 Sep 11.

3.

Clinical and microbiological parameters of naturally occurring periodontitis in the non-human primate Macaca mulatta.

Colombo APV, Paster BJ, Grimaldi G, Lourenço TGB, Teva A, Campos-Neto A, McCluskey J, Kleanthous H, Van Dyke TE, Stashenko P.

J Oral Microbiol. 2017 Nov 25;9(1):1403843. doi: 10.1080/20002297.2017.1403843. eCollection 2017.

4.

Organic solvent exposure and contrast sensitivity: comparing men and women.

Oliveira AR, Campos Neto AA, de Andrade MJO, de Medeiros PCB, Dos Santos NA.

Braz J Med Biol Res. 2018 Jan 11;51(3):e6568. doi: 10.1590/1414-431X20176568.

5.

Discovery of a unique Mycobacterium tuberculosis protein through proteomic analysis of urine from patients with active tuberculosis.

Pollock N, Dhiman R, Daifalla N, Farhat M, Campos-Neto A.

Microbes Infect. 2018 Apr;20(4):228-235. doi: 10.1016/j.micinf.2017.12.011. Epub 2018 Jan 3.

6.

Chronic Organic Solvent Exposure Changes Visual Tracking in Men and Women.

de Oliveira AR, Campos Neto AA, Bezerra de Medeiros PC, de Andrade MJO, Dos Santos NA.

Front Neurosci. 2017 Nov 30;11:666. doi: 10.3389/fnins.2017.00666. eCollection 2017.

7.

CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum.

Lopes CS, Daifalla N, Das B, Dias da Silva V, Campos-Neto A.

PLoS One. 2016 Sep 13;11(9):e0162927. doi: 10.1371/journal.pone.0162927. eCollection 2016.

8.

Novel Antigen Detection Assay to Monitor Therapeutic Efficacy of Visceral Leishmaniasis.

Abeijon C, Singh OP, Chakravarty J, Sundar S, Campos-Neto A.

Am J Trop Med Hyg. 2016 Oct 5;95(4):800-802. Epub 2016 Aug 1.

9.

Mycobacterium tuberculosis strain 18b, a useful non-virulent streptomycin dependent mutant to study latent tuberculosis as well as for in vivo and in vitro testing of anti-tuberculosis drugs.

Campos-Neto A.

Tuberculosis (Edinb). 2016 Jul;99:54-5. doi: 10.1016/j.tube.2016.04.006. Epub 2016 Apr 23. No abstract available.

PMID:
27450005
10.

Correction: Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.

Xie E, Kotha A, Biaco T, Sedani N, Zou J, Stashenko P, Duncan MJ, Campos-Neto A, Cayabyab MJ.

PLoS One. 2016 Jan 22;11(1):e0147781. doi: 10.1371/journal.pone.0147781. eCollection 2016. No abstract available.

11.

Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14kDa Leishmania infantum recombinant polypeptide.

Abeijon C, Daifalla N, Krautz-Peterson G, Pizzirani S, Beamer G, Frazatti-Gallina NM, Raw I, Campos-Neto A.

Trials Vaccinol. 2016;5:1-7.

12.

Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.

Xie E, Kotha A, Biaco T, Sedani N, Zou J, Stashenko P, Duncan MJ, Campos-Neto A, Cayabyab MJ.

PLoS One. 2015 Nov 30;10(11):e0143422. doi: 10.1371/journal.pone.0143422. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0147781.

13.

The hidden 'mycobacteriome' of the human healthy oral cavity and upper respiratory tract.

Macovei L, McCafferty J, Chen T, Teles F, Hasturk H, Paster BJ, Campos-Neto A.

J Oral Microbiol. 2015 Feb 13;7:26094. doi: 10.3402/jom.v7.26094. eCollection 2015.

14.

Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination.

Daifalla N, Cayabyab MJ, Xie E, Kim HB, Tzipori S, Stashenko P, Duncan M, Campos-Neto A.

Microbes Infect. 2015 Mar;17(3):237-42. doi: 10.1016/j.micinf.2014.11.002. Epub 2014 Dec 15.

15.

Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment.

Beamer G, Major S, Das B, Campos-Neto A.

Am J Pathol. 2014 Dec;184(12):3170-5. doi: 10.1016/j.ajpath.2014.08.024. Epub 2014 Oct 16.

16.

An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.

Cayabyab MJ, Qin L, Kashino SS, Izzo A, Campos-Neto A.

Vaccine. 2013 Oct 1;31(42):4834-40. doi: 10.1016/j.vaccine.2013.07.077. Epub 2013 Aug 9.

17.

Potential non-invasive urine-based antigen (protein) detection assay to diagnose active visceral leishmaniasis.

Abeijon C, Campos-Neto A.

PLoS Negl Trop Dis. 2013 May 30;7(5):e2161. doi: 10.1371/journal.pntd.0002161. Print 2013. Review. No abstract available.

18.

Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis.

Pollock NR, Macovei L, Kanunfre K, Dhiman R, Restrepo BI, Zarate I, Pino PA, Mora-Guzman F, Fujiwara RT, Michel G, Kashino SS, Campos-Neto A.

J Clin Microbiol. 2013 May;51(5):1367-73. doi: 10.1128/JCM.03192-12. Epub 2013 Feb 6.

19.

CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis.

Das B, Kashino SS, Pulu I, Kalita D, Swami V, Yeger H, Felsher DW, Campos-Neto A.

Sci Transl Med. 2013 Jan 30;5(170):170ra13. doi: 10.1126/scitranslmed.3004912.

20.

Current and novel approaches to vaccine development against tuberculosis.

Cayabyab MJ, Macovei L, Campos-Neto A.

Front Cell Infect Microbiol. 2012 Dec 6;2:154. doi: 10.3389/fcimb.2012.00154. eCollection 2012. Review.

21.

Identification and diagnostic utility of Leishmania infantum proteins found in urine samples from patients with visceral leishmaniasis.

Abeijon C, Kashino SS, Silva FO, Costa DL, Fujiwara RT, Costa CH, Campos-Neto A.

Clin Vaccine Immunol. 2012 Jun;19(6):935-43. doi: 10.1128/CVI.00125-12. Epub 2012 Apr 18.

22.

Identification of Leishmania infantum chagasi proteins in urine of patients with visceral leishmaniasis: a promising antigen discovery approach of vaccine candidates.

Kashino SS, Abeijon C, Qin L, Kanunfre KA, Kubrusly FS, Silva FO, Costa DL, Campos D Jr, Costa CH, Raw I, Campos-Neto A.

Parasite Immunol. 2012 Jul;34(7):360-71. doi: 10.1111/j.1365-3024.2012.01365.x.

23.

Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol.

Cayabyab MJ, Kashino SS, Campos-Neto A.

Immunology. 2012 Mar;135(3):216-25. doi: 10.1111/j.1365-2567.2011.03525.x.

24.

Successful expression and purification of DPPD using a codon optimized synthetic gene.

Kashino SS, Campos-Neto A.

Open J Immunol. 2011 Jun 1;1(1):1-7. Epub 2011 Jun 30.

25.

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.

Nascimento E, Fernandes DF, Vieira EP, Campos-Neto A, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Kahn SJ, Beckmann AM, Pine SO, Cowgill KD, Reed SG, Piazza FM.

Vaccine. 2010 Sep 14;28(40):6581-7. doi: 10.1016/j.vaccine.2010.07.063. Epub 2010 Aug 3.

PMID:
20688040
26.

Initiation of acquired immunity in the lungs of mice lacking lymph nodes after infection with aerosolized Mycobacterium tuberculosis.

Kashino SS, Vallerskog T, Martens G, Troudt J, Keyser A, Taylor J, Izzo A, Kornfeld H, Campos-Neto A.

Am J Pathol. 2010 Jan;176(1):198-204. doi: 10.2353/ajpath.2010.090446. Epub 2009 Dec 11.

27.

Regulatory T cells in mouse periapical lesions.

AlShwaimi E, Purcell P, Kawai T, Sasaki H, Oukka M, Campos-Neto A, Stashenko P.

J Endod. 2009 Sep;35(9):1229-33. doi: 10.1016/j.joen.2009.06.006.

28.

Cross-sectional and longitudinal epidemiologic surveys of human and canine Leishmania infantum visceral infections in an endemic rural area of southeast Brazil (Pancas, Espirito Santo).

Falqueto A, Ferreira AL, dos Santos CB, Porrozzi R, da Costa MV, Teva A, Cupolillo E, Campos-Neto A, Grimaldi G Jr.

Am J Trop Med Hyg. 2009 Apr;80(4):559-65.

PMID:
19346375
29.

Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results.

Pollock NR, Kashino SS, Napolitano DR, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E, Campos-Neto A.

Infect Control Hosp Epidemiol. 2009 Apr;30(4):392-5. doi: 10.1086/596606.

30.

Identification of highly specific and cross-reactive antigens of Leishmania species by antibodies from Leishmania (Leishmania) chagasi naturally infected dogs.

Vale AM, Fujiwara RT, da Silva Neto AF, Miret JA, Alvarez DC, da Silva JC, Campos-Neto A, Reed S, Mayrink W, Nascimento E.

Zoonoses Public Health. 2009 Feb;56(1):41-8. doi: 10.1111/j.1863-2378.2008.01183.x. Epub 2008 Nov 1.

PMID:
18990196
31.

Guinea pig model of Mycobacterium tuberculosis latent/dormant infection.

Kashino SS, Napolitano DR, Skobe Z, Campos-Neto A.

Microbes Infect. 2008 Nov-Dec;10(14-15):1469-76. doi: 10.1016/j.micinf.2008.08.010. Epub 2008 Sep 6.

32.

Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?

Pollock NR, Campos-Neto A, Kashino S, Napolitano D, Behar SM, Shin D, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E.

Infect Control Hosp Epidemiol. 2008 Sep;29(9):878-86. doi: 10.1086/590262.

33.

Identification and characterization of Mycobacterium tuberculosis antigens in urine of patients with active pulmonary tuberculosis: an innovative and alternative approach of antigen discovery of useful microbial molecules.

Kashino SS, Pollock N, Napolitano DR, Rodrigues V Jr, Campos-Neto A.

Clin Exp Immunol. 2008 Jul;153(1):56-62. doi: 10.1111/j.1365-2249.2008.03672.x. Epub 2008 May 5.

34.

Th1 biased response to a novel Porphyromonas gingivalis protein aggravates bone resorption caused by this oral pathogen.

Leshem O, Kashino SS, Gonçalves RB, Suzuki N, Onodera M, Fujimura A, Sasaki H, Stashenko P, Campos-Neto A.

Microbes Infect. 2008 May;10(6):664-72. doi: 10.1016/j.micinf.2008.03.003. Epub 2008 Mar 25.

35.

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.

Miret J, Nascimento E, Sampaio W, França JC, Fujiwara RT, Vale A, Dias ES, Vieira E, da Costa RT, Mayrink W, Campos Neto A, Reed S.

Vaccine. 2008 Mar 17;26(12):1585-94. doi: 10.1016/j.vaccine.2008.01.026. Epub 2008 Feb 4.

PMID:
18328956
36.

Identification of Mycobacterium tuberculosis ornithine carboamyltransferase in urine as a possible molecular marker of active pulmonary tuberculosis.

Napolitano DR, Pollock N, Kashino SS, Rodrigues V Jr, Campos-Neto A.

Clin Vaccine Immunol. 2008 Apr;15(4):638-43. doi: 10.1128/CVI.00010-08. Epub 2008 Feb 27.

37.

Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs.

Porrozzi R, Santos da Costa MV, Teva A, Falqueto A, Ferreira AL, dos Santos CD, Fernandes AP, Gazzinelli RT, Campos-Neto A, Grimaldi G Jr.

Clin Vaccine Immunol. 2007 May;14(5):544-8. Epub 2007 Feb 21.

38.

Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis.

Stashenko P, Gonçalves RB, Lipkin B, Ficarelli A, Sasaki H, Campos-Neto A.

Am J Pathol. 2007 Jan;170(1):203-13.

39.

Immunotherapy for drug-refractory mucosal leishmaniasis.

Badaro R, Lobo I, Munos A, Netto EM, Modabber F, Campos-Neto A, Coler RN, Reed SG.

J Infect Dis. 2006 Oct 15;194(8):1151-9. Epub 2006 Sep 15.

PMID:
16991091
40.

Unique model of dormant infection for tuberculosis vaccine development.

Kashino SS, Ovendale P, Izzo A, Campos-Neto A.

Clin Vaccine Immunol. 2006 Sep;13(9):1014-21.

41.

T-cell expression cloning of Porphyromonas gingivalis genes coding for T helper-biased immune responses during infection.

Gonçalves RB, Leshem O, Bernards K, Webb JR, Stashenko PP, Campos-Neto A.

Infect Immun. 2006 Jul;74(7):3958-66.

42.

Cloning of the gene encoding a protective Mycobacterium tuberculosis secreted protein detected in vivo during the initial phases of the infectious process.

Mukherjee S, Kashino SS, Zhang Y, Daifalla N, Rodrigues V Jr, Reed SG, Campos-Neto A.

J Immunol. 2005 Oct 15;175(8):5298-305.

43.

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.

Fujiwara RT, Vale AM, França da Silva JC, da Costa RT, Quetz Jda S, Martins Filho OA, Reis AB, Corrêa Oliveira R, Machado-Coelho GL, Bueno LL, Bethony JM, Frank G, Nascimento E, Genaro O, Mayrink W, Reed S, Campos-Neto A.

Vet Res. 2005 Sep-Dec;36(5-6):827-38.

44.

Standardization of a rapid immunochromatographic test with the recombinant antigens K39 and K26 for the diagnosis of canine visceral leishmaniasis.

da Costa RT, França JC, Mayrink W, Nascimento E, Genaro O, Campos-Neto A.

Trans R Soc Trop Med Hyg. 2003 Nov-Dec;97(6):678-82.

PMID:
16117962
45.

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

Campos-Neto A.

Braz J Med Biol Res. 2005 Jul;38(7):979-84. Epub 2005 Jul 4. Review.

46.

Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41.

Skeiky YA, Alderson MR, Ovendale PJ, Lobet Y, Dalemans W, Orme IM, Reed SG, Campos-Neto A.

Vaccine. 2005 Jun 10;23(30):3937-45. Epub 2005 Mar 30.

PMID:
15917115
47.
48.

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.

Skeiky YA, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, Campos-Neto A, Lobet Y, Dalemans W, Orme IM, Reed SG.

J Immunol. 2004 Jun 15;172(12):7618-28.

49.
50.

Potential serological use of a recombinant protein that is a replica of a Mycobacterium tuberculosis protein found in the urine of infected mice.

Mukherjee S, Daifalla N, Zhang Y, Douglass J, Brooks L, Vedvick T, Houghton R, Reed SG, Campos-Neto A.

Clin Diagn Lab Immunol. 2004 Mar;11(2):280-6.

Supplemental Content

Loading ...
Support Center